Stay updated on Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.

Latest updates to the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record now shows an unknown current status and says it was last verified in October 2022 by the Hellenic Society of Hematology. Links to contact information and participant eligibility are no longer shown.SummaryDifference1.0%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study record and its history remain unchanged.SummaryDifference0.1%

- Check22 days agoChange DetectedA sitewide notice announces NIH website transition updates and explains that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference0.9%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, with no change to the study record.SummaryDifference0.1%

- Check36 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1. The study record and history shown remain unchanged.SummaryDifference0.1%

- Check57 days agoChange DetectedThe 'Find contact information' link text is updated from 'Find Contact Information' to 'Find contact information'. The revision notes show the addition of v3.7.0 and removal of v3.6.6.SummaryDifference0.3%

Stay in the know with updates to Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.